Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Berek

Showing results (51-60 of 172) with videos related to

Pageof 18
Sort By:
Obstetrics and Gynecology|August 1, 1981
Laparoscopy for second-look evaluation in ovarian cancerJ S Berek, C T Griffiths, J M Leventhal
The Western Journal of Medicine|July 1, 1990
Pathophysiology and management of endometrial hyperplasia and carcinomaY S Fu, J C Gambone, J S Berek
Natural Immunity and Cell Growth Regulation|January 1, 1988
Immunologic control of ovarian cancerJ Zighelboim, Y Nio, J S Berek, et al.
Obstetrics and Gynecology|March 1, 1994
Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyomaW H Parker, Y S Fu, J S Berek
Gynecologic Oncology|January 1, 1991
Fine-needle aspiration cytology accuracy with palpable gynecologic neoplasmsL J Layfield, J M Heaps, J S Berek
Obstetrics and Gynecology|October 1, 1989
Synergistic effect of combined intraperitoneal cisplatin and cytosine arabinoside in a murine ovarian cancer modelJ S Berek, J C Schink, R M Knox
Endocrinology|April 1, 1973
The physiological response to aldosterone in adrenalectomized and intact rats and its sex dependenceD J Morris, J S Berek, R P Davis
Gynecologic Oncology|June 1, 1990
Cytoreductive surgery for advanced ovarian cancer: cardiovascular evaluation with pulmonary artery cathetersR F Eisner, F J Montz, J S Berek
Gynecologic Oncology|June 1, 1989
Synchronous primary neoplasms of the female reproductive tractR F Eisner, R K Nieberg, J S Berek
Gynecologic Oncology|September 1, 1990
Synergy is documented in vitro with low-dose recombinant tumor necrosis factor, cisplatin, and doxorubicin in ovarian cancer cellsB Bonavida, T Tsuchitani, J Zighelboim, et al.
Pageof 18

Showing results (51-60 of 172) with videos related to

Sort By:
Pageof 18
Obstetrics and Gynecology|August 1, 1981
Laparoscopy for second-look evaluation in ovarian cancerJ S Berek, C T Griffiths, J M Leventhal
The Western Journal of Medicine|July 1, 1990
Pathophysiology and management of endometrial hyperplasia and carcinomaY S Fu, J C Gambone, J S Berek
Natural Immunity and Cell Growth Regulation|January 1, 1988
Immunologic control of ovarian cancerJ Zighelboim, Y Nio, J S Berek, et al.
Obstetrics and Gynecology|March 1, 1994
Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyomaW H Parker, Y S Fu, J S Berek
Gynecologic Oncology|January 1, 1991
Fine-needle aspiration cytology accuracy with palpable gynecologic neoplasmsL J Layfield, J M Heaps, J S Berek
Obstetrics and Gynecology|October 1, 1989
Synergistic effect of combined intraperitoneal cisplatin and cytosine arabinoside in a murine ovarian cancer modelJ S Berek, J C Schink, R M Knox
Endocrinology|April 1, 1973
The physiological response to aldosterone in adrenalectomized and intact rats and its sex dependenceD J Morris, J S Berek, R P Davis
Gynecologic Oncology|June 1, 1990
Cytoreductive surgery for advanced ovarian cancer: cardiovascular evaluation with pulmonary artery cathetersR F Eisner, F J Montz, J S Berek
Gynecologic Oncology|June 1, 1989
Synchronous primary neoplasms of the female reproductive tractR F Eisner, R K Nieberg, J S Berek
Gynecologic Oncology|September 1, 1990
Synergy is documented in vitro with low-dose recombinant tumor necrosis factor, cisplatin, and doxorubicin in ovarian cancer cellsB Bonavida, T Tsuchitani, J Zighelboim, et al.
Pageof 18